FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14341711000001105: Doxazosin 2mg tablets 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50668501000001116 Doxazosin 2mg tablets 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50668601000001117 Doxazosin 2mg tablets 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxazosin 2mg tablets 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Is pack of Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has active ingredient Doxazosin mesilate false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has VMP Product containing precisely doxazosin (as doxazosin mesilate) 2 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Doxazosin 2mg tablets 14 tablet Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cardura 2mg tablets (Sigma Pharmaceuticals Plc) 14 tablet Is a True Doxazosin 2mg tablets 14 tablet Inferred relationship Existential restriction modifier
Cardura 2mg tablets (Necessity Supplies Ltd) 14 tablet Is a True Doxazosin 2mg tablets 14 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start